CAPTRUST FINANCIAL ADVISORS - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$30,750
+2975.0%
20,500
+4000.0%
0.00%
Q2 2022$1,0000.0%5000.0%0.00%
Q1 2022$1,000
-50.0%
500
-64.6%
0.00%
Q4 2021$2,0000.0%1,411
+36.6%
0.00%
Q3 2021$2,0000.0%1,033
+106.6%
0.00%
Q2 2021$2,000
-60.0%
5000.0%0.00%
Q1 2021$5,0000.0%5000.0%0.00%
Q4 2020$5,0000.0%5000.0%0.00%
Q3 2020$5,000
-54.5%
5000.0%0.00%
Q2 2020$11,0005000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders